Green Thumb Industries (GTII) AI Stock Analysis

• Market Cap: $1.91B
• Dividend Yield: N/A
• Average Volume (3M): 126.34K
• Price to Earnings (P/E): 32.0
• Beta (1Y): 0.87
• Revenue Growth: 6.18%
• EPS Growth: -28.69%
• Country: CA
• Employees: 4,900
• Sector: Healthcare
• Sector Strength: 45
• Industry: Drug Manufacturers - Specialty & Generic
• EPS (TTM): 0.14
• Shares Outstanding: 207,360,930
• 10 Day Avg. Volume: 158,079
• 30 Day Avg. Volume: 126,341
• PEG Ratio: 0.25
• Price to Book (P/B): 1.09
• Price to Sales (P/S): 1.72
• P/FCF Ratio: 17.03
• Enterprise Value/Market Cap: 1.57
• Enterprise Value/Revenue: 2.60
• Enterprise Value/Gross Profit: 5.04
• Enterprise Value/Ebitda: 8.86
• 1Y Price Target: $21.63
• Price Target Upside: 162.13% Upside
• Rating Consensus: Strong Buy
• Number of Analyst Covering: 3
• EPS Forecast (FY): 0.21
• Revenue Forecast (FY): $1.64B

• Rating: 62 Neutral
• Price Target: C$8.50 ▲(3.03% Upside)

Green Thumb Industries' overall stock score reflects solid financial performance and strategic growth initiatives, tempered by technical weakness and valuation concerns. The company's revenue growth and operational efficiency are strong, but challenges such as price compression and regulatory uncertainties weigh on the outlook. The technical indicators suggest bearish momentum, and the high P/E ratio indicates potential overvaluation.

Positive Factors

Revenue Growth

Consistent revenue growth indicates strong market demand and effective business strategies, supporting long-term expansion and market penetration.

Strong Brand Performance

Strong brand performance enhances competitive advantage and customer loyalty, contributing to sustained revenue and market share growth.

Cash Flow and Share Buyback

Robust cash flow and share buybacks indicate financial health and confidence in future growth, enhancing shareholder value and investment appeal.

Negative Factors

Price Compression Challenges

Price compression pressures margins, reducing profitability and potentially impacting long-term financial performance and strategic flexibility.

Regulatory and Market Uncertainties

Regulatory uncertainties hinder strategic planning and market expansion, posing risks to growth and operational stability in the evolving cannabis industry.

Increased SG&A Expenses

Rising SG&A expenses can strain profitability, necessitating cost management to maintain margins and support sustainable long-term growth.

Green Thumb Industries Business Overview & Revenue Model

Company Description

Green Thumb Industries (GTII) is a leading national cannabis consumer packaged goods company and retail operator. Founded in 2014, GTII operates in the cannabis sector, focusing on the cultivation, manufacturing, and distribution of cannabis products, including flower, edibles, and concentrates. The company also owns and operates retail facilities under the brand name RISE, providing a diverse range of cannabis products to consumers across various states in the U.S. GTII is committed to promoting responsible cannabis use and enhancing consumer experiences through high-quality products and innovative offerings.

How the Company Makes Money

Green Thumb Industries generates revenue primarily through the sale of cannabis products across its retail locations and wholesale distribution to third-party retailers. The company has multiple revenue streams, including direct sales from its RISE dispensaries, wholesale supply agreements with other dispensaries, and the sale of its branded product lines. Additionally, GTII benefits from partnerships with cultivators and manufacturers that enhance its product offerings and market reach. The expanding legalization of cannabis in various states and GTII's strategic acquisitions further contribute to its earnings, allowing the company to tap into new markets and increase its customer base.

Green Thumb Industries Financial Statement Overview

Summary

Green Thumb Industries demonstrates strong revenue growth and operational efficiency, as evidenced by solid profit margins and cash flow metrics. However, the decline in net profit margin and return on equity suggests potential areas for improvement in profitability and shareholder returns. The balance sheet remains stable with manageable leverage, supporting the company's growth prospects.

Income Statement

Green Thumb Industries shows a solid revenue growth trajectory with a TTM growth rate of 14.9%, indicating strong market demand. The gross profit margin remains healthy at 52.5%, though slightly lower than previous years. Net profit margin has decreased to 4.4% TTM from 6.4% in 2024, suggesting some pressure on net earnings. EBIT and EBITDA margins are robust, reflecting efficient operational management.

Balance Sheet

The company's debt-to-equity ratio is stable at 0.29 TTM, indicating a balanced approach to leveraging. Return on equity has decreased to 1.6% TTM, which may point to challenges in generating returns on shareholder investments. The equity ratio remains strong, suggesting a solid asset base relative to liabilities.

Cash Flow

Operating cash flow is strong, with a coverage ratio close to 1, indicating good cash generation relative to net income. Free cash flow has grown significantly by 41.7% TTM, showing improved cash efficiency. The free cash flow to net income ratio is healthy, reflecting effective cash management.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	1.15B	1.14B	1.05B	1.02B	893.56M	556.57M
Gross Profit	595.19M	601.11M	526.50M	503.96M	491.93M	304.17M
EBITDA	338.34M	392.00M	324.14M	270.28M	329.53M	200.39M
Net Income	28.96M	73.08M	36.27M	11.98M	75.44M	14.99M
Balance Sheet
Total Assets	2.55B	2.54B	2.49B	2.43B	2.39B	1.36B
Cash, Cash Equivalents and Short-Term Investments	176.92M	171.69M	161.63M	177.68M	230.42M	83.76M
Total Debt	522.74M	530.70M	570.28M	535.86M	431.69M	249.34M
Total Liabilities	748.82M	747.93M	786.80M	768.10M	766.37M	444.39M
Stockholders Equity	1.79B	1.79B	1.70B	1.67B	1.62B	910.62M
Cash Flow
Free Cash Flow	127.61M	115.00M	4.93M	-20.94M	-55.80M	36.12M
Operating Cash Flow	221.68M	195.18M	224.97M	158.56M	132.05M	95.92M
Investing Cash Flow	-153.45M	-89.54M	-227.91M	-219.95M	-280.73M	-57.27M
Financing Cash Flow	-87.44M	-95.59M	-13.11M	8.64M	295.34M	-1.55M

Green Thumb Industries Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 8.25
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:GTII, the sentiment is Negative. The current price of 8.25 is below the 20-day moving average (MA) of 9.22, below the 50-day MA of 10.36, and below the 200-day MA of 9.16, indicating a bearish trend. The MACD of -0.77 indicates Positive momentum. The RSI at 40.36 is Neutral, neither overbought nor oversold. The STOCH value of 9.02 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:GTII.

Green Thumb Industries Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
GTII	62 Neutral	$1.91B	31.96	2.42%	―	6.18%	-28.69%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
TRUL	48 Neutral	C$1.26B	―	-9.95%	―	4.27%	3.41%
ACB	47 Neutral	C$362.43M	―	-10.76%	―	23.87%	-19.57%
CL	45 Neutral	C$440.47M	―	-11.79%	―	-6.48%	22.63%
CURA	44 Neutral	C$2.85B	―	-27.61%	―	-3.38%	-31.35%
VRNO	43 Neutral	$2.17B	―	-33.01%	―	-4.58%	-141.91%

Green Thumb Industries Corporate Events

Green Thumb Industries Reports Solid Q3 2025 Results

Green Thumb Industries Inc. is a prominent national cannabis consumer packaged goods company and retailer, headquartered in Chicago, Illinois, known for its diverse portfolio of branded cannabis products and ownership of RISE Dispensaries.

Green Thumb Industries Reports Q3 2025 Financial Results and Expands Adult-Use Cannabis Sales

Green Thumb Industries reported its financial results for the third quarter of 2025, showing a revenue of $291.4 million, a 1.6% increase from the previous year. The company achieved a GAAP net income of $23.3 million and an adjusted EBITDA of $80.2 million, representing 27.5% of revenue. Significant operational highlights include the commencement of adult-use cannabis sales at seven RISE Dispensaries in Minnesota, with the eighth following shortly after. These developments underscore Green Thumb’s strategic expansion in the adult-use cannabis market, potentially enhancing its market positioning and stakeholder value.

The most recent analyst rating on (TSE:GTII) stock is a Hold with a C$11.50 price target. To see the full list of analyst forecasts on Green Thumb Industries stock, see the TSE:GTII Stock Forecast page.

Green Thumb Industries Sells Subsidiary to Agrify

On August 27, 2025, Green Thumb Industries announced the sale of its subsidiary VCP IP Holdings, LLC to Agrify Corporation for $50 million, transferring intellectual property rights of several brands. Concurrently, a license agreement was established allowing Green Thumb to continue manufacturing and distributing these brands. Additionally, Green Thumb extended a $45 million loan to Agrify, secured by a convertible note, which may be converted into Agrify common stock or pre-funded warrants, subject to certain conditions. These transactions are expected to impact Green Thumb’s operations by streamlining its brand management while maintaining a stake in Agrify, potentially influencing its market positioning and stakeholder interests.

The most recent analyst rating on (TSE:GTII) stock is a Buy with a C$11.50 price target. To see the full list of analyst forecasts on Green Thumb Industries stock, see the TSE:GTII Stock Forecast page.